Improving systemic delivery of oncolytic virus by cellular carriers
Oncolytic virotherapy (OVT) is a promising option for cancer treatment. OVT involves selective oncolytic virus (OV) replication within cancer cells, which triggers anti-tumor responses and immunostimulation. Despite promising potential, OVT faces critical challenges, including insufficient tumor-spe...
Saved in:
Main Authors: | Ziyi Peng, Muhammad Kalim, Yong Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2024-12-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | https://www.cancerbiomed.org/content/21/12/1104 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic advancements in breast cancer treatment: a review
by: Marzieh Shokoohi, et al.
Published: (2025-02-01) -
Advances in preclinical and clinical studies of oncolytic virus combination therapy
by: Wenlong Du, et al.
Published: (2025-02-01) -
Diphtheria case detection and carrier study of close contacts: A step towards diphtheria eradication
by: Shilpa R. Shah, et al.
Published: (2024-04-01) -
Virus-inspired biogenic delivery system for advancing cancer therapy
by: Di Sun, et al.
Published: (2025-03-01) -
Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches
by: Ayyaz Khan, et al.
Published: (2025-02-01)